Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Improving intradermal drug delivery by highly accurate injection of small volumes in the skin

Latest news

Colli-Pee® Variants

Novosanis launches volume variants of Colli-Pee® offering new applications in urine testing

We are excited to announce the launch of volume variants of Colli-Pee® , our innovative urine-capturing device offering additional applications in the fields of infectious disease, uro-oncology and more.

Latest blogpost

Towards a world without STIs – Urine sampling offers easy and efficient collection and is a more preferred testing method
Urine has great potential in improving detection of several sexually transmitted infections (STIs). Read more about latest research in our blog.

Upcoming event



Novosanis will be attending the 17th Meeting of the EAU Section of Oncological Urology in Dublin from 17 to 19 January 2020.